Reed & Mackay has teamed up with risk management company Healix International to
launch a risk assessment tool as part of its R&M Protect and Care platform.
The tool will provide instant assessments of the medical and
logistical risks posed for any proposed travel itinerary.
Healix International chief medical officer, Dr Adrian Hyzler,
said: “This tool allows any organisation to have the confidence to deploy
employees safely and with the knowledge that those travelling do not pose a
high medical risk of severe disease.”
Fred Stratford, group CEO, Reed & Mackay said, “We are
thrilled to enter into an exclusive agreement with Healix International to
deliver an impressive tool to our client base that enables them to better
understand the risks posed by each specific itinerary and in relation to the
traveller's unique health profile.”
The TMC has also signed a deal with CityDoc to offer Covid‐19
tests which can be booked at the same time as travel and with results returned within
72 hours of the test sample reaching the lab.
Stratford added, “Being able to access a test for Covid‐19
is now a necessary part of travelling on business.”